Carla Treloar
Carla Treloar
Verified email at
Cited by
Cited by
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
A Doab, C Treloar, GJ Dore
Clinical Infectious Diseases 40 (Supplement_5), S313-S320, 2005
Understanding barriers to hepatitis C virus care and stigmatization from a social perspective
C Treloar, J Rance, M Backmund
Clinical Infectious Diseases 57 (suppl_2), S51-S55, 2013
Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: Utility of a mixed methods approach
L Brener, W von Hippel, C von Hippel, I Resnick, C Treloar
Drug and Alcohol Review 29 (5), 491-497, 2010
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study
M Alavi, J Grebely, M Micallef, AJ Dunlop, AC Balcomb, CA Day, ...
Clinical Infectious Diseases 57 (suppl_2), S62-S69, 2013
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis
T Rhodes, C Treloar
Addiction 103 (10), 1593-1603, 2008
Single index of multimorbidity did not predict multiple outcomes
JE Byles, C D'Este, L Parkinson, R O'Connell, C Treloar
Journal of clinical epidemiology 58 (10), 997-1005, 2005
Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals
C Treloar, J Newland, J Rance, M Hopwood
Journal of viral hepatitis 17 (12), 839-844, 2010
The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis
C Treloar, T Rhodes
Qualitative Health Research 19 (9), 1321-1334, 2009
‘Spoiled identity’in hepatitis C infection: The binary logic of despair
S Fraser, C Treloar
Critical Public Health 16 (2), 99-110, 2006
Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with Hepatitis C
C Waldby, M Rosengarten, C Treloar, S Fraser
Social science & medicine 59 (7), 1461-1471, 2004
Factors affecting progress of Australian and international students in a problem‐based learning medical course
C Treloar, N McCall, I Rolfe, SA Pearson, G Garvey, A Heathcote
Medical education 34 (9), 708-715, 2000
Some characteristics of early‐onset injection drug users prior to and at the time of their first injection
J Abelson, C Treloar, J Crawford, S Kippax, I Van Beek, J Howard
Addiction 101 (4), 548-555, 2006
Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting
J Bryant, L Brener, P Hull, C Treloar
Drug and Alcohol Dependence 107 (2-3), 182-187, 2010
Equity of access to treatment, and barriers to treatment for illicit drug use in Australia
E Digiusto, C Treloar
Addiction 102 (6), 958-969, 2007
Pleasure and drugs
M Holt, C Treloar
International Journal of Drug Policy 5 (19), 349-352, 2008
The gendered context of initiation to injecting drug use: evidence for women as active initiates
J Bryant, C Treloar
Drug and alcohol review 26 (3), 287-293, 2007
The cross cultural context of obesity: an INCLEN multicentre collaborative study
C Treloar, J Porteous, F Hassan, N Kasniyah, M Lakshmanudu, M Sama, ...
Health & place 5 (4), 279-286, 1999
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs
C Treloar, P Hull, GJ Dore, J Grebely
Drug and alcohol review 31 (7), 918-924, 2012
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study
J Grebely, M Alavi, M Micallef, AJ Dunlop, AC Balcomb, N Phung, ...
Addiction 111 (2), 311-319, 2016
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia
J Grebely, J Bryant, P Hull, M Hopwood, Y Lavis, GJ Dore, C Treloar
Journal of viral hepatitis 18 (4), e104-e116, 2011
The system can't perform the operation now. Try again later.
Articles 1–20